We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$145B
AUM Growth
+$1.75B
Cap. Flow
+$95.7M
Cap. Flow %
0.07%
Top 10 Hldgs %
12.04%
Holding
10,318
New
561
Increased
3,567
Reduced
4,243
Closed
1,510

Sector Composition

Rank Sector Weight
1 Financials 8.78%
2 Energy 7.49%
3 Healthcare 7.07%
4 Technology 6.57%
5 Consumer Discretionary 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSG
2726
DELISTED
CHAMBERS STR PPTYS COM
CSG
$2.48M ﹤0.01%
314,639
+180,065
+134% +$1.48M
SKT icon
2727
Tanger
SKT
$4.52B
$2.48M ﹤0.01%
70,442
-11,604
-14% -$433K
SNX icon
2728
TD Synnex
SNX
$20.2B
$2.48M ﹤0.01%
64,166
+46,214
+257% +$1.78M
CXO
2729
DELISTED
CONCHO RESOURCES INC.
CXO
$2.48M ﹤0.01%
21,371
-24,424
-53% -$2.66M
THC icon
2730
PUT
Tenet Healthcare
THC
$21.1B
$2.48M ﹤0.01%
50,000
-600
-1% -$28K
MUC icon
2731
BlackRock MuniHoldings California Quality Fund
MUC
$1.01B
$2.47M ﹤0.01%
167,933
+11,199
+7% +$165K
TARO
2732
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.47M ﹤0.01%
17,538
+9,643
+122% +$1.48M
NTRI
2733
DELISTED
NutriSystem, Inc.
NTRI
$2.47M ﹤0.01%
123,520
+6,348
+5% +$118K
IOVA icon
2734
Iovance Biotherapeutics
IOVA
$2.87B
$2.46M ﹤0.01%
+203,500
New +$2.29M
PBYI icon
2735
PUT
Puma Biotechnology
PBYI
$454M
$2.46M ﹤0.01%
10,400
+9,800
+1,633% +$2.09M
SNDK
2736
CALL
DELISTED
SANDISK CORP
SNDK
$2.46M ﹤0.01%
38,600
-52,800
-58% -$4.29M
VIMC
2737
DELISTED
VIMICRO INTERNATIONAL CORP ADR (KY)
VIMC
$2.46M ﹤0.01%
262,741
+132,106
+101% +$1.14M
VRN
2738
DELISTED
Veren
VRN
$2.45M ﹤0.01%
113,130
+10,952
+11% +$250K
HIO
2739
Western Asset High Income Opportunity Fund
HIO
$340M
$2.45M ﹤0.01%
460,580
+16,696
+4% +$89.6K
VTRS icon
2740
PUT
Viatris
VTRS
$18.9B
$2.45M ﹤0.01%
41,300
-164,400
-80% -$9.37M
HEWJ icon
2741
iShares Currency Hedged MSCI Japan ETF
HEWJ
$744M
$2.45M ﹤0.01%
81,025
+76,778
+1,808% +$2.2M
PRLB icon
2742
Protolabs
PRLB
$2.13B
$2.45M ﹤0.01%
34,988
+7,262
+26% +$492K
MELI icon
2743
Mercado Libre
MELI
$92.3B
$2.45M ﹤0.01%
19,965
-84,081
-81% -$10.6M
DTRE icon
2744
First Trust Alerian Disruptive Technology Real Estate ETF
DTRE
$14.6M
$2.44M ﹤0.01%
54,085
+19,690
+57% +$894K
FFA
2745
First Trust Enhanced Equity Income Fund
FFA
$467M
$2.44M ﹤0.01%
169,691
-17,004
-9% -$246K
HCF
2746
DELISTED
NEXPOINT CREDIT STRATEGIES FUND
HCF
$2.44M ﹤0.01%
200,626
+63,303
+46% +$771K
BAX icon
2747
CALL
Baxter International
BAX
$14.2B
$2.44M ﹤0.01%
65,540
+8,469
+15% +$321K
COST icon
2748
CALL
Costco
COST
$420B
$2.44M ﹤0.01%
16,100
-4,700
-23% -$690K
AES.PRC.CL
2749
DELISTED
AES Corporation Class C Preferred
AES.PRC.CL
$2.44M ﹤0.01%
47,779
+42,233
+762% +$2.15M
HES
2750
PUT
DELISTED
Hess
HES
$2.44M ﹤0.01%
35,900
-7,100
-17% -$506K

Similar funds

UBS Group's Q1 2015 Portfolio in Review

As of Q1 2015, UBS Group held 10,318 positions worth $145B, up 1.2% from $143B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

UBS Group's Q1 2015 filing shows 561 new, 3,567 increased, 4,243 reduced and 1,510 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 200,030 shares worth $202M. The largest sale was Qualcomm, an estimated $294M.

By sector, the portfolio is most concentrated in Financials at 8.8% of assets, up from 8.8% a quarter earlier, followed by Energy and Healthcare.

  • UBS Group's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 200,030 shares worth $202M.
  • UBS Group added most to Yum! Brands in Q1 2015, an estimated $674M increase.
  • UBS Group's biggest Q1 2015 reduction was Qualcomm, cutting an estimated $294M.
  • UBS Group fully exited Allergan Inc in Q1 2015, selling an estimated $210M.
  • UBS Group's ten largest holdings make up 12% of its $145B portfolio in Q1 2015.
  • UBS Group opened 561 new positions and closed 1,510 in Q1 2015.
  • UBS Group's portfolio value rose 1.2% quarter-over-quarter to $145B.

Based on UBS Group's 13F filing for Q1 2015, filed 14 May 2015.